On Monday, Lennox International Inc. (NYSE:LII)’s shares declined -4.19% to $106.72.
Lennox International Inc. (LII) stated financial results for the first quarter of 2015. Financial results reflect sold businesses in suspended operations.
Revenue for the first quarter was $686 million, down 1% from the preceding-year quarter counting the negative influence from foreign exchange. At constant currency, revenue was up 2%, led by 7% growth in the Residential business. Adjusted earnings per share from ongoing operations were $0.37 contrast to $0.42 in the preceding-year quarter. On a GAAP basis, earnings per share from ongoing operations were $0.31 contrast to $0.40 in the preceding-year quarter.
Lennox International Inc., through its auxiliaries, designs, manufactures, and markets climate control products for the heating, ventilation, air conditioning, and refrigeration markets.
EXCO Resources Inc (NYSE:XCO)’s shares dropped -3.79% to $2.03.
EXCO Resources Inc (XCO) declared that it will be releasing first quarter 2015 results on Tuesday, April 28, 2015, after market close.
EXCO will host a conference call on Wednesday, April 29, 2015, at 9:00 a.m. (Central Time) to talk about the contents of this release and respond to questions.
EXCO Resources, Inc., an independent oil and natural gas company, engages in the acquisition, exploration, exploitation, development, and production of onshore oil and natural gas properties with a focus on shale resource plays in the United States.
At the end of Monday’s trade, EXACT Sciences Corporation (NASDAQ:EXAS)‘s shares dipped -3.77% to $22.99.
EXACT Sciences Corporation (EXAS) declared that the company will host a webcast and conference call on May 4, 2015 to talk about its first-quarter 2015 financial results.
Moreover, declared expanded patient access to Cologuard as a result of several insurers now covering the test. Cologuard is now covered for more than 90 million Medicare and commercial lives across the U.S.
Exact Sciences Corporation, a molecular diagnostics company, focuses on developing non-invasive colorectal cancer screening products. The company develops the Cologuard, a non-invasive stool-based DNA colorectal cancer screening test that is designed to detect pre-cancerous lesions or polyps, and each of the four stages of colorectal cancer.
CONSOL Energy Inc. (NYSE:CNX), ended its Monday’s trading session with -3.50% loss, and closed at $30.05.
CONSOL Energy Inc. (CNX) will issue its first quarter earnings release at 6:45 a.m. Eastern Time on Tuesday, April 28. This will be followed by a conference call at 10:00 a.m. Eastern Time. The webcast and presentation materials will be accessible on the ‘Investor Relations’ page of the company’s website, www.consolenergy.com.
CONSOL Energy Inc., together with its auxiliaries, operates as an integrated energy company in the United States and internationally. The company operates through two divisions, Exploration and Production (E&P), and Coal. The E&P division produces pipeline quality natural gas primarily to gas wholesalers.
DISCLAIMER:
This article is published by www.wsnewspublishers.com. The Content included in this article is just for informational purposes only. All information used in this article is believed to be from reliable sources, but we make no representations or warranties of any kind, express or implied, about the completeness, accuracy, or reliability with respect to this article.
All visitors are advised to conduct their own independent research into individual stocks before making a purchase decision.
Information contained in this article contains forward-looking information within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, counting statements regarding the predictable continual growth of the market for the corporation’s products, the corporation’s ability to fund its capital requirement in the near term and in the long term; pricing pressures; etc.
Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, aims, assumptions, or future events or performance may be forward looking statements. Forward-looking statements are based on expectations, estimates, and projections at the time the statements are made that involve a number of risks and uncertainties which could cause actual results or events to differ materially from those presently anticipated. Forward looking statements may be identified through the use of such words as expects, will, anticipates, estimates, believes, or by statements indicating certain actions may, could, should might occur.
